Skip to main content

and
  1. Article

    Open Access

    Benefits for children with suspected cancer from routine whole-genome sequencing

    Clinical whole-genome sequencing (WGS) has been shown to deliver potential benefits to children with cancer and to alter treatment in high-risk patient groups. It remains unknown whether offering WGS to every ...

    Angus Hodder, Sarah M. Leiter, Jonathan Kennedy, Dilys Addy in Nature Medicine (2024)

  2. Article

    Open Access

    The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer

    Whole-genome sequencing (WGS) of cancers is becoming an accepted component of oncological care, and NHS England is currently rolling out WGS for all children with cancer. This approach was piloted during the 1...

    Jamie Trotman, Ruth Armstrong, Helen Firth, Claire Trayers in British Journal of Cancer (2022)

  3. Article

    Correction: Corrigendum: Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus

    Nat. Genet. 38, 1242–1244 (2006); published online 1 October 2006; corrected after print 6 June 2011 In the version of this article initially published, the author Andrew Bastawrous was omitted from the author...

    Patrick Tarpey, Shery Thomas, Nagini Sarvananthan, Uma Mallya in Nature Genetics (2011)

  4. No Access

    Article

    Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus

    Idiopathic congenital nystagmus is characterized by involuntary, periodic, predominantly horizontal oscillations of both eyes. We identified 22 mutations in FRMD7 in 26 families with X-linked idiopathic congenita...

    Patrick Tarpey, Shery Thomas, Nagini Sarvananthan, Uma Mallya in Nature Genetics (2006)

  5. No Access

    Article

    A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer

    We examined the coding sequence of 518 protein kinases, ∼1.3 Mb of DNA per sample, in 25 breast cancers. In many tumors, we detected no somatic mutations. But a few had numerous somatic mutations with distinct...

    Philip Stephens, Sarah Edkins, Helen Davies, Chris Greenman, Charles Cox in Nature Genetics (2005)